Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Hypomethylating agent (HMA) failure in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) carries a poor prognosis with limited treatment options. Although intensive, remission induction chemotherapy is often used subsequently, in particular to bridge to allogeneic transplantation, it...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Ball, Brian, Komrokji, Rami S., Adès, Lionel, Sekeres, Mikkael A., DeZern, Amy E., Pleyer, Lisa, Vey, Norbert, Almeida, Antonio, Germing, Ulrich, Cluzeau, Thomas, Platzbecker, Uwe, Gore, Steven D., Fenaux, Pierre, Prebet, Thomas
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2018
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113613/
https://ncbi.nlm.nih.gov/pubmed/30120104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018015529
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker